Abstract
In order to determine whether ionotropic (iGluRs) and metabotropic (mGluRs) glutamate receptor activation modulates oxytocin release in male rats, we investigated the effect of agonists of both types of glutamate receptors on oxytocin release from hypothalamus and posterior pituitary. Kainate and quisqualate (1 mM) increased hypothalamic oxytocin release. Their effects were prevented by selective AMPA/kainate receptor antagonists. NMDA (0.01–1 mM) did not modify hypothalamic oxytocin release. Group I mGluR agonists, such as quisqualate and 3-HPG, significantly increased hypothalamic oxytocin release. These effects were blocked by AIDA (a selective antagonist of group I mGluRs). In the posterior pituitary, oxytocin release was not modified by kainate, quisqualate, trans-ACPD (a broad-spectrum mGluR agonist) and l-SOP (a group III mGluR agonist). However, NMDA (0.1 mM) significantly decreased oxytocin release from posterior pituitary. d-Aspartate significantly increased oxytocin release from the hypothalamus, while it decreased oxytocin release from posterior pituitary. AP-5 (a specific NMDA receptor antagonist) reduced the d-Aspartate effect in the hypothalamus, but not in the posterior pituitary. Our data indicate that the activation of non-NMDA receptors and group I mGluRs stimulates oxytocin release from hypothalamic nuclei, whereas NMDA inhibits oxytocinergic terminals in the posterior pituitary. d-Aspartate also has a dual effect on oxytocin release: stimulatory at the hypothalamus and inhibitory at the posterior pituitary. These results suggest that excitatory amino acids differentially modulate the secretion of oxytocin at the hypothalamic and posterior pituitary levels.
Similar content being viewed by others
References
Silverman, A. J. and Zimmerman, E. A. (1983). Annu. Rev. Neurosci. 6, 251–262.
Ben Jonathan, N., Laudon, M., and Garris, P. (1991). Front. Neuroendocrinol. 12, 231–277.
Morris, J. F., Christian, H., Ma, D., and Wang, H. (2000). Exp. Physiol. 85S, 131S-138S.
Page, W. K., King, W. M., Merigan, W., and Maunsell, J. (1994). Vision Res. 34, 223–239.
De Wied, D., Diamant, M., and Fodor, M. (1993). Front. Neuroendocrinol. 14, 251–302.
Engelmann, M., Wotjak, C. T., Neumann, I., Ludwig, M., and Landgraf, R. (1996). Neurosci. Biobehav. Rev. 20, 341–358.
Chalmers, J. and Pilowsky, P. (1991). J. Hypertens. 9, 675–694.
Huang, W., Lee, S. L., and Sjoquist, M. (1995). Am. J. Physiol. 268, R634-R640.
Van del Pol, A. N., Wuarin, J. P., and Dudek, F. (1990). Science 250, 1276–1278.
Brann, D. W. and Mahesh, V. B. (1997). Endocrine Rev. 18, 678–700.
Schoepp, D. D. and Conn, P. J. (1993). TIPS 14, 13–20.
Meeker, R. B., Swanson, D. J., Greenwood, R. S., and Hayward, J. N. (1993). Brain Res. 600, 112–122.
El Majdoubi, M., Poulain, D. A., and Theodosis, D. T. (1996). Eur. J. Neurosci. 8, 1377–1398.
Morris, J. F., Pow, D. V., Sokol, H. W., and Ward, A. (1993). In: Vasopressin. Gross, P., Richter, D., and Robertson, G.L. (eds.). John Libbey Eurotext: Paris.
Ginsberg, S. D., Price, D. L., Blackstone, C. D., Huganir, R. L., and Martin, L. J. (1995). Neuroscience 65, 563–575.
Martin, D., Blackstone, C. D., Levey, A. I., Huganir, R. L., and Price, D. L. (1993). Neuroscience 53, 327–358.
Petralia, R. S. and Wenthold, R. J. (1992). J. Comp. Neurol. 318, 329–354.
Sato, K., Kiyama, H., and Tohyama, M. (1993). Neuroscience 52, 515–539.
Van del Pol, A. N., Herman-Borgmeyer, I., Hofer, M., Ghosh, P., and Heinemann, S. (1994). J. Comp. Neurol. 343, 428–444.
Sato, K., Kiyama, H., and Tohyama, M. (1995). Neuroscience 64, 459–475.
Meeker, R. B., Greenwood, R. S., and Hayward, J. N. (1994). Endocrinology 134, 621–629.
Van den Pol, A. N. (1994). J. Comp. Neurol. 349, 615–632.
Petralia, R. S., Wang, Y. X., Niedzielski, A. S., and Wenthold, R. J. (1996). Neuroscience 71, 949–976.
Lasaga, M., De Laurentiis, A., Pampillo, M., Pisera, D., Díaz, M., Theas, S., Duvilanski, B., and Seilicovich, A. (1998). Neurosc. Letts. 247, 119–122.
Hattori, T., Sundberg, D. K., and Morris, M. (1992). Brain Res. Bull. 28, 257–263.
Moos, F. C., Rossi, K., and Richards, P. (1997). Neuroscience 77, 993–1002.
Parker, S. L. and Crowley, W. R. (1993). Endocrinology 133, 2847–2854.
Hashimoto, A., Nishikawa, T., Oka, T., Hayashi, T., and Takahashi, K. (1993). FEBS Lett. 27, 4–8.
Schell, M. J., Cooper, O. B., and Snyder, S. H. (1997). Proc. Natl. Acad. Sci. USA 94, 2013–2018.
Bleakman, D. and Lodge, D. (1998). Neuropharmacology 37, 1187–1204.
Hu, B. and Bourque, C. W. (1992). J. Physiol. 458, 667–687.
Petralia, R. S., Wang, Y. X., and Wenthold, R. J. (1994). J. Neurosci. 14, 6102–6120.
Nissen, R., Hu, B., and Renaud, L. P. (1995). J. Physiol. London 484, 415–424.
Nissen, R., Hu, B., and Renaud, L. P. (1994). Neuroscience 59, 115–120.
Stern, J. E., Galarreta, M., Foehring, R. C., Hestrin, S., and Armstrong, W. E. (1999). J. Neurosci. 19, 3367–3375.
Morsette, D. J., Sidorowicz, H., and Sladek, C. (2001). Am. J. Physiol. Regulatory Integrative Comp. Physiol. 280, R313-R322.
Boudaba, C., Szabó, K., and Tasker, J. G. (1997). J. Neurophysiol. 77, 3396–3400.
Richardson, C. M., and Wakerley, J. B. (1997). Brain Res. 767, 158–161.
Sun, Q., Pretel, S., Applegate, C. D., and Piekut, D. T. (1996). Neuroscience 71, 543–554.
Jourdain, P., Poulain, D. A., Theodosis, D. T., and Israel, J. M. (1996). J. Neurophysiol. 76, 2272–2285.
Schrader, L. A. and Tasker, J. G. (1997). J. Neurophysiol. 78, 3428–3437.
Hashimoto, A. and Oka, T. (1997). Progr. Neurobiol. 52, 325–353.
Lee, J., Homma, H., Tashiro, K., Iwatsubo, T., and Imai, K. (1999). Brain Res. 838, 193–199.
Long, Z., Homma, H., Lee, J., Fukushima, T., Santa, T., Iwatsubo, T., Yamada, R., and Imai, K. (1998). FEBS Lett. 434, 231–235.
D’Aniello, A., Difiore, M. M., Fisher, G. H., Milone, A., Seleni, A., D’Aniello, S., Perna, A. F., and Ingrosso, D. (2000). FASEB J. 14, 699–714.
Wang, H., Wolosker, H., Pevsner, J., Snyder, S. H., and Selkoe, D. J. (2000). J. Endocrinol. 167, 247–252.
Al-Ghoul, W. M., Meeker, R. B., and Greenwood, R. S. (1997). Mol. Brain Res. 44, 262–272.
Wafford, K. A., Bain, C. J., Le Bourdelles, B., Whiting, P. J., and Kemp, J. A. (1993). Neuroreport 4, 1347–1349.
Nagata, Y., Homma, H., Lee, J., and Imai, K. (1999). FEBS Lett. 444, 160–164.
Di Fiore, M., Assisi, L., Botte, V., and D’Aniello, A. (1998). J. Endocrinol. 157, 199–207.
Kendrick, K. M. (2000). Exp. Physiol. 85S, 111S-124S.
Richard, P., Moos, F. C., and Freund-Mercier, M. J. (1991). Physiol. Rev. 71, 331–370.
Ludwig, M. (1998). J. Neuroendocrinology 10, 881–895.
Pow, D. V. and Morris, J. F. (1989). Neuroscience 32, 435–439.
Pittman, Q. J., Hirasawa, M., Mouginot, D., and Kombian, S. B. (2000). Exp. Physiol. 85S, 139S-143S.
De Laurentiis, A., Pisera, D., Duvilanski, B., Rettori, V., Lasaga, M., and Seilicovich, A. (2000). Brain Res. Bull. 53, 325–330.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pampillo, M., del Carmen Díaz, M., Duvilanski, B.H. et al. Differential effects of glutamate agonists and d-aspartate on oxytocin release from hypothalamus and posterior pituitary of male rats. Endocr 15, 309–315 (2001). https://doi.org/10.1385/ENDO:15:3:309
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:15:3:309